Natsumi Fukuhara

Dr. Natsumi Fukuhara

Vascular Surgery Department
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1993 in Neurology
Verified
Journal Article
Closed access
YTY. Tanno
Y. Tanno
MYM. Yoneda
M. Yoneda
KTKeiko Tanaka
Keiko Tanaka
RKR. Kondo
R. Kondo
Isao HozumiIsao Hozumi
Isao Hozumi
STS. Tsuji
S. Tsuji
We documented the presence of a point mutation in the tRNA(Lys) gene of mitochondrial DNA (mtDNA) in various postmortem tissues from two patients with myoclonus epilepsy associated with ragged-red fibers (MERRF). The percentages of the mutant mtDNA were similar (93 to 99%) in both clinically affected and unaffected tissues, suggesting that preferential clinical involvement of certain tissues in MERRF is based not only on the variation of distribution of the mutant mtDNA, but also on other factors such as differences in the threshold in various CNS regions and organs.

Verified
Journal Article
Open access
PDF file
NFNatsumi Fukuhara
Natsumi Fukuhara
YHYuto Honda
Yuto Honda
NUNao Ukita
Nao Ukita
MMMakoto Matsui
Makoto Matsui
YMYutaka Miura
Yutaka Miura
Katsuyuki HoshinaKatsuyuki Hoshina
Katsuyuki Hoshina
Abdominal aortic aneurysm (AAA) is a life-threatening disease. However, no systemically injectable drug has been approved for AAA treatment due to low bioavailability. Polymeric micelles are nanomedicines that have the potential to improve therapeutic efficacy by selectively delivering drugs into disease sites, and research has mainly focused on cancer treatments. Here, we developed a statin-loaded polymeric micelle to treat AAAs in rat models. The micelle showed medicinal efficacy by preventing aortic aneurysm expansion in a dose-dependent manner. Furthermore, the micelle-injected group showed decreased macrophage infiltration and decreased matrix metalloproteinase-9 activity in cases of AAA.

24 February 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
KMKazuyoshi Matsubara
Kazuyoshi Matsubara
NFNatsumi Fukuhara
Natsumi Fukuhara
Katsuyuki HoshinaKatsuyuki Hoshina
Katsuyuki Hoshina
KMKazuhiro Miyahara
Kazuhiro Miyahara
MSMasamitsu Suhara
Masamitsu Suhara
TTToshio Takayama
Toshio Takayama
Background: Arterial deterioration is mostly caused by atherosclerosis, which progresses with age. However, we have observed serious backgrounds or etiologies in younger patients with non-atherosclerotic diseases and deterioration of small-to-medium-sized arterial lesions. Therefore, we aimed to identify the specific features of patients aged <40 years with deterioration of small-to-medium-sized arteries.Methods: We selected patients who were admitted to our department from 1995 to 2019 with deterioration of small-to-medium-sized arteries (aneurysms, dissection, rupture, or arterial injury/damage) and focused on the cohort aged <40 years. We examined the backgrounds or etiologies of the patients including genetic and inflammatory diseases, which might have caused the arterial deterioration.Results: Consequently, more than half (54.1%) of the patients aged <40 years had non-atherosclerotic comorbid diseases. However, the number of deteriorated arterial lesions was higher in patients aged <40 years than in patients aged ≥40 years (3.13 vs. 1.33 lesion/patient; P = 0.011). Furthermore, the data analysis of patients with multiple arterial lesions (≥3) revealed that the younger population tended to have more specific backgrounds or etiologies, notably Ehlers-Danlos syndrome and Behçet's disease. There were no differences in the all-cause mortality and cardiovascular disease-related mortality between patients aged <40 and ≥40 years (P = 0.89 and 0.29, respectively).Conclusions: Over 50% of patients aged <40 years with deterioration of small-to-medium-sized arteries had non-atherosclerotic, specific clinical backgrounds or etiologies, including genetic and inflammatory diseases. In addition, they exhibited more arterial lesions than older patients.